Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0780-2024Class II

Model A710 Intellis Clinician Programmer Application, version 2.0.97

Medtronic Neuromodulation / initiated 2023-12-19 / Open, Classified

Medtronic Neuromodulation began a recall of Model A710 Intellis Clinician Programmer Application, version 2.0.97 on . FDA classified it as Class II and gives the reason as "Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0780-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic Neuromodulation
Product
Model A710 Intellis Clinician Programmer Application, version 2.0.97
Product code
LGW Stimulator, Spinal-Cord, Totally Implanted For Pain Relief
Reason for recall
Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may receive inadequate or excessive therapy and experience non-optimal pain relief.
FDA root cause
Under Investigation by firm
Action
OUS communication to a single German consignee will be initiated via regionally approved methods beginning 19-Dec-2023. A field service technician will go to the site and reset the INS to resolve the issue.
Quantity in commerce
1 tablet
Distribution
Germany
Product codes and lots
UDI/DI 00763000520076, S/N: NPL1000519

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0780-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0780-2024Class IIOngoingVoluntary: Firm initiated